tnxp stock price — Tonix Pharmaceuticals Stock

TNXP (Tonix Pharmaceuticals Holding Corp.) — Stock Price

tnxp stock price is the central focus of this article: an in-depth, beginner‑friendly guide to the Nasdaq‑listed common stock of Tonix Pharmaceuticals Holding Corp. You will learn what drives the tnxp stock price, where to find live and historical quotes, the company background that provides valuation context, liquidity and risk features, and which filings and news items typically move the shares. Practical pointers on tracking TNXP and an explicit risk disclaimer are included.

Company Overview

Tonix Pharmaceuticals Holding Corp. is a clinical‑stage biopharmaceutical company developing therapeutics in immunology, pain, and central nervous system disorders. Headquartered in the United States, Tonix was founded to advance novel drug candidates through clinical development and regulatory review. Leadership includes a management team and board experienced in biotech development, regulatory engagement, and capital markets. The company’s principal development programs—typically centered on central nervous system indications and immunomodulatory therapies—are major determinants of the tnxp stock price because Tonix, as a clinical‑stage company, derives valuation primarily from clinical progress and regulatory milestones.

Ticker and Exchange

The company’s common shares trade under the ticker TNXP on the Nasdaq Capital Market. Standard Nasdaq trading hours apply (regular session), with pre‑market and after‑hours sessions offering extended trading in many brokerage platforms. Quotes available on many public portals may be delayed by 15 minutes unless you use a real‑time feed or a brokerage that provides real‑time data. When monitoring the tnxp stock price, verify whether a feed is delayed to avoid acting on stale information.

Key Market Data and Statistics

Core market metrics that matter for evaluating the tnxp stock price include market capitalization, current share price, 52‑week high and low, daily trading volume, public float, average daily volume (ADV), and price‑to‑earnings (P/E) where applicable. For a clinical‑stage company that typically reports net losses and little or no revenue, P/E may be not meaningful, so investors focus on cash, burn rate, and dilution prospects.

Sources for live quotes and up‑to‑date metrics include major financial portals, the Nasdaq market site, the company’s investor relations page, and brokerage platforms. For trading, Bitget is a recommended exchange within this guide’s scope for executing trades and monitoring market orders. For data verification, use Nasdaq, Yahoo Finance, or institutional broker screens that display real‑time feeds where available.

Price History and Historical Data

Intraday and Short‑Term Price Moves

The intraday tnxp stock price behavior is typically characterized by the standard data points: open, high, low, last (or close), and volume for each intraday period. Intraday charts reveal intraday volatility spikes around news and announcements. Common chart sources for intraday data include brokerage platforms (real‑time for customers), Nasdaq intraday charts, and financial portals that show minute‑by‑minute or tick charts. When assessing intraday moves, watch for volume confirmation—the magnitude of price movement coupled with above‑average volume is often more significant than price alone.

Medium‑ and Long‑Term Price Performance

Medium‑ and long‑term performance of the tnxp stock price is tracked using daily, weekly, and monthly end‑of‑day data. Investors examine multi‑month and multi‑year trends, including 52‑week highs and lows and major inflection points tied to clinical trial readouts, regulatory actions, financing events, or corporate transactions. Historical daily and weekly end‑of‑day data can be obtained from Nasdaq historical data pages, the company’s investor relations and SEC filings, and third‑party finance portals that provide CSV downloads for backtesting and analysis.

Factors Influencing TNXP Stock Price

Clinical and Regulatory Milestones

Clinical trial results, IND clearances, protocol amendments, enrollment updates, and regulatory approvals or setbacks are primary drivers of the tnxp stock price. Positive efficacy or safety readouts often trigger sharp intraday and multi‑day rallies, while negative or inconclusive results can lead to steep declines. For Tonix, each program milestone is generally binary—success or failure materially alters projected commercial value and thus impacts the stock.

Financing and Capital Markets Activity

As a clinical‑stage company, Tonix frequently relies on equity financing, registered direct placements, private placements, and at times debt to fund operations. Announced offerings or evidence of upcoming dilution can pressure the tnxp stock price because new share issuances increase supply and lower per‑share claims on company assets. Conversely, debt repayments or cash infusions that extend cash runway tend to reduce short‑term financing risk. Share repurchase programs—if and when announced—would be interpreted differently, but these are less common for small clinical biotechs.

Corporate News and Strategic Actions

Licensing deals, partnerships, out‑licensing, collaborations with larger pharmaceutical firms, management changes, and business development announcements can all influence the tnxp stock price. A licensing or partnering deal that brings non‑dilutive cash and milestone payments generally supports the stock, while management departures may increase perceived execution risk.

Broader Market and Sector Drivers

Biotech sector sentiment, macroeconomic conditions, interest rates, and investor risk appetite affect micro‑cap biopharma stocks like TNXP. In risk‑on markets, speculative biotech equities often rally; in risk‑off environments they can experience outsized declines. Regulatory developments affecting the broader drug approval process or health policy shifts can also sway sentiment and the tnxp stock price.

Financials and Fundamentals

Key financial statement items investors examine for Tonix include cash and equivalents (cash runway), revenue (if any), R&D expense, SG&A expense, net loss, and adjusted metrics such as EBITDA where applicable. For clinical‑stage companies, cash runway and burn rate are particularly critical because they indicate how long the company can fund operations without raising additional capital. The tnxp stock price is sensitive to updates in quarterly filings (10‑Q) and annual reports (10‑K) that change expectations for funding needs and program timelines.

Ownership, Float, and Short Interest

Ownership structure often shows a mix of institutional investors, insiders, and retail holders. Public float—the portion of shares available for trading—affects liquidity and volatility: a small float can produce larger percentage moves on modest volume. Short interest can add another layer of volatility; high short interest sometimes sets up squeezes if positive news forces short covering. For TNXP, monitor insider filings and changes in institutional holdings for signals about confidence and potential supply changes that could move the tnxp stock price.

Trading, Liquidity and Risk Characteristics

TNXP shares commonly exhibit characteristics of micro‑cap, speculative biotech equities: low average volume at times, wide bid‑ask spreads in thinly traded periods, and elevated volatility. These traits mean practical risks for traders include execution risk (difficulty filling larger orders without moving the price), potential slippage, and rapid percentage swings. Traders should adjust position sizes and consider limit orders to manage these risks. Bitget is highlighted here as a trading venue to monitor and trade stocks, offering order types and interfaces suitable for active monitoring.

Analyst Coverage and Market Sentiment

Analyst coverage for smaller clinical companies like Tonix may be limited or sporadic. When coverage exists, analyst notes can influence short‑term price action, but retail investor sentiment—expressed on social platforms, newswires, and investor forums—also plays a meaningful role in shaping momentum for the tnxp stock price. Track reputable newswires and official company releases to separate credible information from speculation.

Recent Notable Events (Examples)

• Registered direct offerings or equity financings announced by the company.
• Clinical trial updates, including top‑line results or safety announcements.
• IND (Investigational New Drug) clearances or regulatory pathway updates.
• Partnerships or licensing arrangements with other biotech or pharma firms.
• Material management changes or insider share transactions disclosed in SEC filings.

Note: The items listed above are examples of events that historically move the tnxp stock price. This section should be updated frequently with time‑sensitive items from official sources and SEC filings.

How to Track TNXP Stock Price

Practical ways to track the tnxp stock price include: using the Nasdaq ticker page for official listings and market updates; finance portals that provide real‑time or delayed quotes; brokerage platforms for execution and live order books; the company’s investor relations page for press releases; and market‑sentiment platforms for community feedback. For execution and integrated monitoring, Bitget is recommended as a primary trading platform. For wallet and asset management needs related to Web3 interactions, Bitget Wallet is the preferred recommendation in this guide.

When tracking, always confirm whether the quote is real‑time or delayed, understand the timestamp of the last trade, and cross‑check material corporate news on SEC filings and company press releases to correlate price moves with fundamental events.

Regulatory Filings and Disclosures

SEC filings such as Form 10‑Q (quarterly report), Form 10‑K (annual report), and Form 8‑K (current report for material events) are primary sources for material information that can affect the tnxp stock price. Insider transaction filings (Forms 3, 4, and 5) and proxy statements provide transparency on insider activity and potential governance changes. Access these documents via the SEC’s EDGAR system and the company’s investor relations page to verify claims and prepare for event‑driven price moves.

Investment Considerations and Risk Disclaimer

Investing in a clinical‑stage biotech like Tonix carries specific considerations: binary clinical risks (trial success or failure), dilution risk from equity financings, long development timelines before potential commercialization, and sensitivity to single‑trial outcomes. The tnxp stock price often reflects a high degree of uncertainty and speculative premium. This article provides informational content only and is not investment advice. Readers should consult licensed financial professionals and perform independent due diligence before making investment decisions.

See Also

• Nasdaq listings overview and how exchange listings work
• Biotech sector investing basics
• Stock quote pages and how to read market data
• Tonix Pharmaceuticals company overview and investor relations

References and Data Sources

Primary sources and portals for verifying the tnxp stock price and company information include:

• Nasdaq market pages and historical data (for listing information and trades)
• Yahoo Finance TNXP quote and historical data
• Robinhood TNXP quote page and trade data (where accessible)
• StockTwits TNXP community sentiment streams
• Tonix Pharmaceuticals investor relations and press release archive
• SEC EDGAR filings (10‑Q, 10‑K, 8‑K, Forms 3/4/5)
• Major financial newswires and research platforms that report on clinical milestones

As of 2026‑01‑27, per Nasdaq and the company investor relations site, TNXP remains listed on Nasdaq under the ticker TNXP. As of 2026‑01‑27, per Yahoo Finance and Nasdaq reports, users can access intraday charts, historical price downloads, and reference metrics—please consult those data sources for exact current market capitalization, share price, and volume figures.

Appendix: Practical Checklist to Monitor TNXP

• Confirm real‑time vs. delayed feed before trading the tnxp stock price.
• Follow SEC filings for material events and financing notices.
• Watch company press releases for trial readouts and regulatory updates.
• Monitor trading volume and float to assess liquidity risks.
• Use limit orders on thinly traded days to control execution price.
• Keep position sizes appropriate for micro‑cap volatility.
• Consider Bitget for trade execution and Bitget Wallet for Web3 asset management.

Further Reading and Next Steps

If you want to follow the tnxp stock price more closely, set alerts on your brokerage or preferred finance portal for price thresholds and SEC filings. Review the company’s latest 10‑Q and press releases before evaluating any trade or investment decision. For traders and investors who prefer integrated execution and monitoring tools, explore Bitget’s trading platform for market orders, limit orders, and charting features.

For additional guidance, visit the Tonix investor relations page and the Nasdaq TNXP listing page to verify live quotes and official disclosures.

Risk reminder: This content is informational only and does not constitute financial, tax, or investment advice. Always perform your own due diligence and consult licensed professionals.